English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community

Technology/Innovation

+ Technology/Innovation
Amanda Rupp | Mar 30, 2016

Axsome enrolls first patient in COAST-1 study

+ Technology/Innovation
Amanda Rupp | Mar 30, 2016

Florida Cancer Affiliates develops spacing tool for prostate cancer patients

+ Technology/Innovation
Amanda Rupp | Mar 30, 2016

Propell Platinum found to use hidden drug ingredients

+ Technology/Innovation
Amanda Rupp | Mar 30, 2016

Eisai creates adjunctive therapy for seizures

+ Technology/Innovation
Amanda Rupp | Mar 29, 2016

Cushing syndrome children found to have increased suicide risk

+ Technology/Innovation
Amanda Rupp | Mar 29, 2016

NHC publishes Patient-Centered Value Model Rubric

+ Technology/Innovation
Amanda Rupp | Mar 29, 2016

Novo Nordisk breaks ground on new facility in Clayton

+ Technology/Innovation
Amanda Rupp | Mar 29, 2016

FDA releases complete letter response for Brintellix treatment

Trending

+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate

+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update

+ Regulatory
M. Y. Bailey | Aug 7, 2026

PhRMA's Zirkelbach: 340B program has changed dramatically with 'little transparency into how patients benefit'

Patient Daily reports | Aug 10, 2026

SoCal Breathe Free warns persistent sinus symptoms may signal chronic inflammation

  • « First
  • «
  • …
  • 464
  • 465
  • 466
  • 467
  • 468
  • 469
  • 470
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2026 Patient Daily